Director/PDMR Shareholding -

RNS Number : 1350Z
GlaxoSmithKline PLC
07 January 2011
 



The Directors/PDMR shareholding announcement released on 7 January at 16.12 pm under RNS No 1318Z should have been issued under the Company name of GlaxoSmithKline Plc and not under the Company name of GlaxoSmithKline Capital Plc

 

The announcement text is unchanged and is reproduced in full below.

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.50 per Ordinary share on 6 January 2011 through the Company's Share Reward Plan ("the Plan").

 

Mr A P Witty

Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr J S Heslop

Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S M Bicknell

Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr E J Gray

Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr S A Hussain

Acquisition of 7 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Dr D Pulman

Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr D S Redfern

Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Ms C Thomas

Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan

 

Mr P J T Vallance

Acquisition of 13 Ordinary shares under the Dividend Reinvestment element of the Plan

 

 

The Company and the above-mentioned persons were advised of this information on 7 January 2011.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

7 January 2011


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAKFXELDFEFF

Companies

GSK (GSK)
UK 100